ICICI Securities has maintained its HOLD rating on Torrent Pharma, nudging up its 12-month target price to Rs 4,800 from Rs 4,600 earlier — a modest 4% upside from

Torrent Pharmaceuticals has emerged from its latest quarter with renewed momentum, and ICICI Securities has kept its stance at BUY with a target of Rs 5,100, implying about 15% upside from the Rs 4

Torrent Pharmaceuticals Ltd.

SBI Life shares jumped 2.08 percent on Friday and the stock is currently trading at Rs 1,830, looking bullish on technical charts.

HDFC AMC, Tata Communications, and Torrent Pharmaceuticals have given bullish breakout on technical charts.

Prabhudas Lilladher has issued an “ACCUMULATE” recommendation on Torrent Pharmaceuticals (TRP), with a target price of Rs3,850 per share.